Meuer S C, Fitzgerald K A, Hussey R E, Hodgdon J C, Schlossman S F, Reinherz E L
J Exp Med. 1983 Feb 1;157(2):705-19. doi: 10.1084/jem.157.2.705.
Monoclonal antibodies were produced against a human cytotoxic T cell clone, CT8III (specificity: HLA-A3), with the view of defining clonally restricted (clonotypic) surface molecules involved in its antigen recognition function. Two individual antibodies, termed anti-Ti1A and anti-Ti1B, reacted exclusively with the CT8III clone when tested on a panel of 80 additional clones from the same donor, resting or activated T cells, B cells, macrophages, thymocytes, or other hematopoietic cells. More importantly, the two antibodies inhibited cell-mediated killing and antigen-specific proliferation of the CT8III clone but did not affect the functions of any other clone tested. This inhibition was not secondary to generalized abrogation of the CT8III clone's function, because interleukin 2 responsiveness was enhanced. To examine the relationship of the structures defined by anti-clonotypic antibodies with known T cell surface molecules, antibody-induced modulation studies and competitive binding assays were performed. The results indicated that the clonotypic structures were associated with, but distinct from, the 20,000-mol wt T3 molecule expressed on all mature T lymphocytes. Moreover, in contrast to anti-T3, anti-Ti1A and anti-Ti1B each immunoprecipitated two molecules of 49,000 and 43,000-mol wt from 131I-labeled CT8III cells under reducing conditions. The development of monoclonal antibodies to such polymorphic T cell surface structures should provide important probes to further define the surface receptor for antigen.
制备了针对人细胞毒性T细胞克隆CT8III(特异性:HLA - A3)的单克隆抗体,目的是确定参与其抗原识别功能的克隆限制性(克隆型)表面分子。当在来自同一供体的另外80个克隆、静息或活化的T细胞、B细胞、巨噬细胞、胸腺细胞或其他造血细胞上进行测试时,两种分别称为抗Ti1A和抗Ti1B的单克隆抗体仅与CT8III克隆发生反应。更重要的是,这两种抗体抑制了CT8III克隆的细胞介导杀伤和抗原特异性增殖,但不影响所测试的任何其他克隆的功能。这种抑制并非继发于CT8III克隆功能的普遍丧失,因为白细胞介素2反应性增强了。为了研究抗克隆型抗体所定义的结构与已知T细胞表面分子的关系,进行了抗体诱导的调节研究和竞争性结合试验。结果表明,克隆型结构与所有成熟T淋巴细胞上表达的20,000道尔顿分子量的T3分子相关,但又有所不同。此外,与抗T3相反,在还原条件下,抗Ti1A和抗Ti1B各自从131I标记的CT8III细胞中免疫沉淀出49,000和43,000道尔顿分子量的两种分子。针对这种多态性T细胞表面结构的单克隆抗体的开发应为进一步确定抗原表面受体提供重要的探针。